Inits Pharma Audit

INITS Pharma Audit is a Paris-based service provider operating in the diagnostics and digital health sectors, though its core business is offering high-value services to biotech companies. The company operates through two main service lines: strategic consulting across the pharmaceutical value chain and a Shared Manufacturing Organization (SMO) for preclinical and clinical trial material production. With a track record of serving over 250 international clients and managing numerous regulatory and quality projects, INITS positions itself as a critical enabler for biotechs navigating complex development pathways. As a private company, it leverages a team of experienced professionals to deliver tailored support, aiming to reduce risk and accelerate timelines for its clients.

Integrated service platform combining regulatory/CMC consulting expertise with a GMP Shared Manufacturing Organization (SMO) for clinical trial material production, supporting biotech, diagnostics, and digital health companies.

INITS competes in a fragmented market against large global CDMOs (e.g., Lonza, Catalent), specialized consulting firms, and niche regional service providers. Its differentiation lies in combining high-touch, strategic consulting with dedicated, agile manufacturing capacity, targeting small-to-midsize biotechs in Europe.